Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis

Systemic sclerosis (SSc) is a rare systemic autoimmune disorder marked by high morbidity and increased risk of mortality. Our study aimed to analyze metabolomic profiles of plasma from SSc patients by using targeted and untargeted metabolomics approaches. Furthermore, we aimed to detect biochemical...

Full description

Bibliographic Details
Main Authors: Thomas Bögl, Franz Mlynek, Markus Himmelsbach, Norbert Sepp, Wolfgang Buchberger, Marija Geroldinger-Simić
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/3/607
_version_ 1797472767071748096
author Thomas Bögl
Franz Mlynek
Markus Himmelsbach
Norbert Sepp
Wolfgang Buchberger
Marija Geroldinger-Simić
author_facet Thomas Bögl
Franz Mlynek
Markus Himmelsbach
Norbert Sepp
Wolfgang Buchberger
Marija Geroldinger-Simić
author_sort Thomas Bögl
collection DOAJ
description Systemic sclerosis (SSc) is a rare systemic autoimmune disorder marked by high morbidity and increased risk of mortality. Our study aimed to analyze metabolomic profiles of plasma from SSc patients by using targeted and untargeted metabolomics approaches. Furthermore, we aimed to detect biochemical mechanisms relevant to the pathophysiology of SSc. Experiments were performed using high-performance liquid chromatography coupled to mass spectrometry technology. The investigation of plasma samples from SSc patients (<i>n</i> = 52) compared to a control group (<i>n</i> = 48) allowed us to identify four different dysfunctional metabolic mechanisms, which can be assigned to the kynurenine pathway, the urea cycle, lipid metabolism, and the gut microbiome. These significantly altered metabolic pathways are associated with inflammation, vascular damage, fibrosis, and gut dysbiosis and might be relevant for the pathophysiology of SSc. Further studies are needed to explore the role of these metabolomic networks as possible therapeutic targets of SSc.
first_indexed 2024-03-09T20:05:54Z
format Article
id doaj.art-826e5e2b4a9b4199bcfdae78b560ebde
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T20:05:54Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-826e5e2b4a9b4199bcfdae78b560ebde2023-11-24T00:32:42ZengMDPI AGBiomedicines2227-90592022-03-0110360710.3390/biomedicines10030607Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic SclerosisThomas Bögl0Franz Mlynek1Markus Himmelsbach2Norbert Sepp3Wolfgang Buchberger4Marija Geroldinger-Simić5Institute of Analytical and General Chemistry, Johannes Kepler University Linz, 4040 Linz, AustriaInstitute of Analytical and General Chemistry, Johannes Kepler University Linz, 4040 Linz, AustriaInstitute of Analytical and General Chemistry, Johannes Kepler University Linz, 4040 Linz, AustriaDepartment of Dermatology, Ordensklinikum Linz Elisabethinen, 4020 Linz, AustriaInstitute of Analytical and General Chemistry, Johannes Kepler University Linz, 4040 Linz, AustriaDepartment of Dermatology, Ordensklinikum Linz Elisabethinen, 4020 Linz, AustriaSystemic sclerosis (SSc) is a rare systemic autoimmune disorder marked by high morbidity and increased risk of mortality. Our study aimed to analyze metabolomic profiles of plasma from SSc patients by using targeted and untargeted metabolomics approaches. Furthermore, we aimed to detect biochemical mechanisms relevant to the pathophysiology of SSc. Experiments were performed using high-performance liquid chromatography coupled to mass spectrometry technology. The investigation of plasma samples from SSc patients (<i>n</i> = 52) compared to a control group (<i>n</i> = 48) allowed us to identify four different dysfunctional metabolic mechanisms, which can be assigned to the kynurenine pathway, the urea cycle, lipid metabolism, and the gut microbiome. These significantly altered metabolic pathways are associated with inflammation, vascular damage, fibrosis, and gut dysbiosis and might be relevant for the pathophysiology of SSc. Further studies are needed to explore the role of these metabolomic networks as possible therapeutic targets of SSc.https://www.mdpi.com/2227-9059/10/3/607systemic sclerosismetabolomicsLC-MS/MSion mobilitykynurenine pathwayurea cycle
spellingShingle Thomas Bögl
Franz Mlynek
Markus Himmelsbach
Norbert Sepp
Wolfgang Buchberger
Marija Geroldinger-Simić
Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis
Biomedicines
systemic sclerosis
metabolomics
LC-MS/MS
ion mobility
kynurenine pathway
urea cycle
title Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis
title_full Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis
title_fullStr Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis
title_full_unstemmed Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis
title_short Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis
title_sort plasma metabolomic profiling reveals four possibly disrupted mechanisms in systemic sclerosis
topic systemic sclerosis
metabolomics
LC-MS/MS
ion mobility
kynurenine pathway
urea cycle
url https://www.mdpi.com/2227-9059/10/3/607
work_keys_str_mv AT thomasbogl plasmametabolomicprofilingrevealsfourpossiblydisruptedmechanismsinsystemicsclerosis
AT franzmlynek plasmametabolomicprofilingrevealsfourpossiblydisruptedmechanismsinsystemicsclerosis
AT markushimmelsbach plasmametabolomicprofilingrevealsfourpossiblydisruptedmechanismsinsystemicsclerosis
AT norbertsepp plasmametabolomicprofilingrevealsfourpossiblydisruptedmechanismsinsystemicsclerosis
AT wolfgangbuchberger plasmametabolomicprofilingrevealsfourpossiblydisruptedmechanismsinsystemicsclerosis
AT marijageroldingersimic plasmametabolomicprofilingrevealsfourpossiblydisruptedmechanismsinsystemicsclerosis